Effect of renin-angiotensin system antihypertensive medication use on cognitive function in diabetes mellitus with obesity or overweight: An ancillary study to the Action for Health in Diabetes (Look AHEAD) trial.
Whitney WhartonAndrea AndersonKathleen M HaydenOwen T CarmichaelJeanne M ClarkJosé A LuchsingerMark A EspelandSevil YasarPublished in: Diabetes, obesity & metabolism (2022)
In this sample of adults with T2DM, free of dementia at baseline, we observed a slower decline in processing speed, executive function, verbal memory, and composite score among RAS-AHM users.
Keyphrases
- glycemic control
- type diabetes
- weight loss
- working memory
- weight gain
- insulin resistance
- healthcare
- public health
- blood pressure
- cardiovascular disease
- metabolic syndrome
- mild cognitive impairment
- clinical trial
- cognitive impairment
- high fat diet induced
- health information
- adipose tissue
- skeletal muscle
- climate change